Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.08 HKD | -0.78% | +12.64% | -26.27% |
Sales 2024 * | 849M 118M 920M | Sales 2025 * | 1.3B 180M 1.41B | Capitalization | 9.4B 1.3B 10.18B |
---|---|---|---|---|---|
Net income 2024 * | -675M -93.52M -731M | Net income 2025 * | -487M -67.47M -528M | EV / Sales 2024 * | -0.23 x |
Net cash position 2024 * | 9.59B 1.33B 10.39B | Net cash position 2025 * | 11.92B 1.65B 12.92B | EV / Sales 2025 * | -1.94 x |
P/E ratio 2024 * |
-11.5
x | P/E ratio 2025 * |
-17.3
x | Employees | 1,089 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 56.11% |
Latest transcript on InnoCare Pharma Limited
1 day | -0.78% | ||
1 week | +12.64% | ||
Current month | +9.72% | ||
1 month | +3.89% | ||
3 months | +0.40% | ||
6 months | -26.80% | ||
Current year | -26.27% |
Managers | Title | Age | Since |
---|---|---|---|
Jisong Cui
CEO | Chief Executive Officer | 62 | 15-11-02 |
Xin Fu
DFI | Director of Finance/CFO | 46 | Dec. 17 |
Kevin Gao
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yigong Shi
FOU | Founder | 57 | 15-11-02 |
Kai Xian Chen
BRD | Director/Board Member | 78 | 20-02-29 |
Jisong Cui
CEO | Chief Executive Officer | 62 | 15-11-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.14% | 4 M€ | -27.92% | ||
0.13% | 2 M€ | -14.14% | ||
0.01% | 0 M€ | +3.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 5.08 | -0.78% | 1,814,000 |
24-05-06 | 5.12 | -4.30% | 6,003,000 |
24-05-03 | 5.35 | +2.10% | 1,483,080 |
24-05-02 | 5.24 | +13.17% | 2,417,721 |
24-04-30 | 4.63 | +2.66% | 3,566,000 |
Delayed Quote Hong Kong S.E., May 07, 2024 at 04:08 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.27% | 1.31B | |
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |
- Stock Market
- Equities
- 9969 Stock